Inhibitors of HIV-Protease from Computational Design. A History of Theory and Synthesis Still to be Fully Appreciated

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|21|3398-3411

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.21, 2014-05, pp. : 3398-3411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heterocyclic HIV-Protease Inhibitors

By  

Current Medicinal Chemistry, Vol. 20, Iss. 30, 2013-10 ,pp. : 3693-3710

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and activity of HIV protease inhibitors

By Garrouste P.   Pawlowski M.   Tonnaire T.   Sicsic S.   Dumy P.   de Rosny E.   Reboud-Ravaux M.   Fulcrand P.   Martinez J.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 6, 1998-06 ,pp. : 423-436

Elsevier

Access to resources Recommend Favorite

Approaches to the Design of Effective HIV-1 Protease Inhibitors

By  

Current Medicinal Chemistry, Vol. 7, Iss. 4, 2000-04 ,pp. : 455-477

Bentham Science Publishers

Access to resources Recommend Favorite

HIV protease inhibitors

By Kuhnert Maren   Diederich Wibke E.  

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 262-269

Govi-Verlag

Access to resources Recommend Favorite

Prodrugs of HIV Protease Inhibitors

By  

Current Pharmaceutical Design, Vol. 9, Iss. 22, 2003-08 ,pp. : 1755-1770

Bentham Science Publishers

Access to resources Recommend Favorite